EMPLOYMENT AGREEMENTEmployment Agreement • October 31st, 2006 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances • Massachusetts
This Employment Agreement (this “Agreement”), is made and entered into as of August 17, 2006 (the “Effective Date”), by and between Interleukin Genetics, Inc. a Delaware corporation (“Employer”), and David A. Finkelstein, an individual (“Employee”).
ASSET PURCHASE AGREEMENT BY AND AMONG ALAN JAMES GROUP, LLC, AJG-NB, LLC, AJG- BI BRANDS, LLC, AJG-GNC, LLC, THE OWNERS OF EACH OF THE FOREGOING, AJG BRANDS, INC. AND INTERLEUKIN GENETICS, INC. August 17, 2006Asset Purchase Agreement • October 31st, 2006 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances • Delaware
This Asset Purchase Agreement (the “Agreement”) is entered into as of August 17, 2006 by and among Alan James Group, LLC, a Florida limited liability company (“AJG”), AJG-NB, LLC, a Florida limited liability company (“AJG-NB”), AJG-BI Brands, LLC, a Florida limited liability company (“AJG-BI”), AJG-GNC, LLC, a Florida limited liability company (“AJG-GNC” and, together with AJG, AJG-NB and AJG-BI, the “Sellers” and each a “Seller”), Timothy J. Richerson (“Richerson”) and David A. Finkelstein (“Finkelstein” and, together with Richerson, the “Owners” and each an “Owner”), the sole owners of membership interests of the Sellers, AJG Brands, Inc. a Delaware corporation (the “Purchaser”), and Interleukin Genetics, Inc., a Delaware corporation (the “Parent”).
STOCK PURCHASE AGREEMENT BETWEEN INTERLEUKIN GENETICS, INC. AND PYXIS INNOVATIONS INC. Dated as of August 17, 2006Stock Purchase Agreement • October 31st, 2006 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances • Delaware
THIS STOCK PURCHASE AGREEMENT (“Agreement”) is made as of the 17th day of August, 2006 by and between INTERLEUKIN GENETICS, INC., a Delaware corporation (the “Company”), and Pyxis Innovations Inc., a Delaware corporation (“Investor”).
AMENDMENT NO. 5 TO NOTE PURCHASE AGREEMENTNote Purchase Agreement • October 31st, 2006 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances
THIS AMENDMENT NO. 5 (the “Amendment”), dated as of August 17, 2006, is by and between INTERLEUKIN GENETICS, INC., a Delaware corporation (the “Company”), and PYXIS INNOVATIONS INC., a Delaware corporation (“Pyxis”).
